MML Investors Services’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,266
| Closed | -$61K | – | 2577 |
|
|
2023
Q4 | $61K | Sell |
2,266
-450
| -17% | -$12.1K | ﹤0.01% | 2413 |
|
|
2023
Q3 | $164K | Buy |
2,716
+1,109
| +69% | +$67K | ﹤0.01% | 2192 |
|
|
2023
Q2 | $164K | Buy |
1,607
+404
| +34% | +$41.2K | ﹤0.01% | 2195 |
|
|
2023
Q1 | $213K | Buy |
1,203
+55
| +5% | +$9.74K | ﹤0.01% | 1880 |
|
|
2022
Q4 | $444K | Sell |
1,148
-51
| -4% | -$19.7K | ﹤0.01% | 1566 |
|
|
2022
Q3 | $404K | Buy |
1,199
+756
| +171% | +$255K | ﹤0.01% | 1535 |
|
|
2022
Q2 | $146K | Buy |
443
+83
| +23% | +$27.4K | ﹤0.01% | 1948 |
|
|
2022
Q1 | $157K | Buy |
+360
| New | +$157K | ﹤0.01% | 1995 |
|
|
2021
Q4 | – | Sell |
-652
| Closed | -$362K | – | 2074 |
|
|
2021
Q3 | $362K | Buy |
+652
| New | +$362K | ﹤0.01% | 1541 |
|